Mike Bogetofte Barnkob
8PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Apr 24, 2024
Publisher Correction: Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8<sup>+</sup> T cells.Mike B Barnkob, Yale S Michaels, Violaine André
|Apr 12, 2024
Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8<sup>+</sup> T cells.Mike B Barnkob, Yale S Michaels, Violaine André
|Aug 03, 2022
Target isoforms are an overlooked challenge and opportunity in chimeric antigen receptor cell therapy.Mike Bogetofte Barnkob, Kristoffer Vitting-Seerup, Lars Rønn Olsen
|Apr 01, 2022
cyCombine allows for robust integration of single-cell cytometry datasets within and across technologies.Christina Bligaard Pedersen, Søren Helweg Dam, Mike Bogetofte Barnkob
|Sep 28, 2021
Harnessing the Immune System to Fight Multiple Myeloma.Jakub Krejcik, Mike Bogetofte Barnkob, Charlotte Guldborg Nyvold
|Jun 12, 2019
Addendum: Precise tuning of gene expression levels in mammalian cells.Yale S Michaels, Mike B Barnkob, Hector Barbosa
Pageof 2
Frequent Collaborators
4 joint publications
Yale S Michaels
4 joint publications
Lars Rønn Olsen
2 joint publications
Mary K Thompson
2 joint publications
Thomas A Milne
2 joint publications
Philip S Macklin
2 joint publications
Uzi Gileadi
2 joint publications
Salvatore Valvo
2 joint publications
Margarida Rei
2 joint publications
Corinna Kulicke
2 joint publications
Vitul Jain
